These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24475405)

  • 1. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.
    Rahimi Z
    J Nephropathol; 2012 Oct; 1(3):143-51. PubMed ID: 24475405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
    Velloso EP; Vieira R; Cabral AC; Kalapothakis E; Santos RA
    Braz J Med Biol Res; 2007 Apr; 40(4):583-90. PubMed ID: 17401503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
    Hunley TE; Julian BA; Phillips JA; Summar ML; Yoshida H; Horn RG; Brown NJ; Fogo A; Ichikawa I; Kon V
    Kidney Int; 1996 Feb; 49(2):571-7. PubMed ID: 8821846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.
    Ruggenenti P; Bettinaglio P; Pinares F; Remuzzi G
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1511-25. PubMed ID: 18550651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
    Krajina-Andricević M; Zibar L; Glavas-Obrovac- L; Stefanić M; Avdicević M; Barbić J
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():14-9. PubMed ID: 23120809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy.
    Hristova M; Stanilova S; Miteva L
    Clin Exp Hypertens; 2019; 41(7):662-669. PubMed ID: 30307755
    [No Abstract]   [Full Text] [Related]  

  • 9. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
    Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
    DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients.
    Oh TG; Shin CS; Park KS; Kim SY; Cho BY; Lee HK; Koh CS
    Korean J Intern Med; 1996 Jun; 11(2):133-7. PubMed ID: 8854649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM.
    Nagi DK; Mansfield MW; Stickland MH; Grant PJ
    Diabet Med; 1995 Nov; 12(11):997-1001. PubMed ID: 8582133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy.
    Ha SK; Park HC; Park HS; Kang BS; Lee TH; Hwang HJ; Kim SJ; Kim DH; Kang SW; Choi KH; Lee HY; Han DS
    Am J Kidney Dis; 2003 May; 41(5):943-9. PubMed ID: 12722028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
    Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
    Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.
    Ha SK
    J Diabetes Res; 2014; 2014():846068. PubMed ID: 25587546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.
    Goyache-Goñi B; Aranda-Lara P; Reyes-Engels A; Frutos-Sanz MA; Hernández-Marrero D
    Nefrologia; 2013 Nov; 33(6):771-8. PubMed ID: 24241364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
    van der Knaap R; Siemes C; Coebergh JW; van Duijn CM; Hofman A; Stricker BH
    Cancer; 2008 Feb; 112(4):748-57. PubMed ID: 18181094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to preterm birth: A case-control study and meta-analysis.
    Hočevar K; Peterlin A; Jovanović AM; Božović A; Ristanović M; Tul N; Peterlin B
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():122-128. PubMed ID: 30366344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.